Loading...

Herborium Group, Inc.

HBRMPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
$-0.00(-99.00%)
U.S. Market opens in 8h 20m

Herborium Group, Inc. (HBRM) Stock Overview

Explore Herborium Group, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap546K
P/E Ratio-3.53
EPS (TTM)N/A
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.00
1 Year Target$0.00

HBRM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Herborium Group, Inc. (HBRM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.53 and a market capitalization of 546K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-50.00%
5-Day Change
-50.00%
1-Month Change
-50.00%
3-Month Change
-50.00%
6-Month Change
-50.00%
Year-to-Date (YTD) Change
N/A
1-Year Change
-50.00%
3-Year Change
-50.00%
5-Year Change
-96.15%
All-Time (Max) Change
-100.00%

Contact Information

201-849-4431
One Bridge Plaza North, Fort Lee, NJ, 07024

Company Facts

2 Employees
IPO DateJul 13, 1998
CountryUS
Actively Trading

Frequently Asked Questions